27 - 29 May, 2026
Congress CenterBasel Switzerland Michael LukeschCEO at Valanx BiotechSpeaker
Profile
Michael Lukesch studied Organic Chemistry and Synthetic Biology at the Graz University of Technology. His passion for applied technology led him to found and lead VALANX Biotech in 2017 until now, focussing on the promise of synthetic amino acids in drug development.
Agenda Sessions
Finding the Golden Site: How Synthetic Amino Acids and Third-generation Click-chemistry Enable the Next Generation of Protein Conjugates
, 14:25View Session